Need For Consensus On Pharmacovigilance For Drugs In Pregnancy Delays New EMA Guideline
Executive Summary
A new draft guideline from the European Medicines Agency on pharmacovigilance requirements relating to medicines taken during pregnancy and breastfeeding has been delayed and will now be issued for stakeholder consultation by the end of 2017.